TAK
TAKEDA PHARMACEUTICAL CO LTD
+0.41 (+2.17%)19.05USD1.3M成交股數–市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-10-29下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 20 · 13.1M · 13 |
| 其中 10b5-1 計畫賣出 | 2 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 13.1M |
| 近 180 天 淨額 | −13.1M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 | 09-15 | Duprey Lauren Rusckowski | Chief Transformation Officer | S 公開市場賣出 | 34.5K | 18.54 | 640K | 192K | SEC |
| 2026-09-02 | 09-03 | Plump Andrew Stewart | President, R&D | S 公開市場賣出(10b5-1) | 116K | 18.49 | 2.1M | 145K | SEC |
| 2026-08-19 | 08-21 | Plump Andrew Stewart | President, R&D | S 公開市場賣出(10b5-1) | 19.7K | 18.49 | 363K | 262K | SEC |
| 2026-08-18 | 08-19 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S 公開市場賣出 | 13.0K | 18.11 | 235K | 40.0K | SEC |
| 2026-08-11 | 08-12 | Shannon Elaine Mary | Pres., Global Supply & Quality | S 公開市場賣出 | 20.4K | 17.55 | 357K | 67.3K | SEC |
| 2026-08-10 | 08-12 | Bitetti Teresa Marie | President, OBU | S 公開市場賣出 | 50.0K | 17.10 | 855K | 252K | SEC |
| 2026-08-10 | 08-12 | Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev | S 公開市場賣出 | 23.0K | 17.10 | 393K | 177K | SEC |
| 2026-08-10 | 08-12 | Plump Andrew Stewart | President, R&D | S 公開市場賣出 | 165K | 17.10 | 2.8M | 767K | SEC |
| 2026-08-10 | 08-12 | Duprey Lauren Rusckowski | Chief Transformation Officer | S 公開市場賣出 | 47.6K | 17.10 | 814K | 226K | SEC |
| 2026-08-10 | 08-12 | Pacheco Rhonda Janice | President, U.S. Business Unit | S 公開市場賣出 | 16.9K | 17.10 | 289K | 183K | SEC |
| 2026-08-10 | 08-12 | Ibrahim Ramy Riad Ahmed | President, PDT BU | S 公開市場賣出 | 7.3K | 17.10 | 124K | 103K | SEC |
| 2026-08-10 | 08-12 | Farajallah Awny Samaan Botros | Chief Medical Officer | S 公開市場賣出 | 14.0K | 17.10 | 240K | 116K | SEC |
| 2026-08-10 | 08-12 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S 公開市場賣出 | 975 | 17.50 | 17K | 93.4K | SEC |
| 2026-08-10 | 08-12 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S 公開市場賣出 | 33.6K | 17.51 | 589K | 59.8K | SEC |
| 2026-08-10 | 08-12 | Platford Giles Richard | President, IBU | S 公開市場賣出 | 31.1K | 17.10 | 532K | 316K | SEC |
| 2026-08-10 | 08-12 | Furney Natalie Anne Marie | Global General Counsel | S 公開市場賣出 | 30.9K | 17.10 | 528K | 204K | SEC |
| 2026-08-10 | 08-12 | Kim Julie So-Young | President and CEO | S 公開市場賣出 | 89.1K | 17.10 | 1.5M | 391K | SEC |
| 2026-08-10 | 08-12 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | S 公開市場賣出 | 6.8K | 17.10 | 116K | 53.0K | SEC |
| 2026-08-10 | 08-12 | Ricci Gabriele | Chief Data & Tech. Officer | S 公開市場賣出 | 25.1K | 17.10 | 429K | 172K | SEC |
| 2026-08-10 | 08-12 | Shannon Elaine Mary | Pres., Global Supply & Quality | S 公開市場賣出 | 4.0K | 17.10 | 68K | 63.3K | SEC |
| 2026-07-01 | 07-06 | Stoffels Paulus | Director | A 獲配股票 | 3.8K | – | – | 3.8K | SEC |
| 2026-07-01 | 07-06 | BROUSSARD BRUCE D | Director | A 獲配股票 | 3.8K | – | – | 4.6K | SEC |
| 2026-07-01 | 07-06 | Iijima Masami | Director | A 獲配股票 | 1.8K | – | – | 14.6K | SEC |
| 2026-07-01 | 07-06 | Reed Kimberly A. | Director | A 獲配股票 | 3.8K | – | – | 10.4K | SEC |
| 2026-07-01 | 07-06 | MARAGANORE JOHN | Director | A 獲配股票 | 3.8K | – | – | 10.4K | SEC |
| 2026-07-01 | 07-06 | GILLIS STEVEN | Director | A 獲配股票 | 3.8K | – | – | 10.4K | SEC |
| 2026-07-01 | 07-06 | Tsusaka Miki | Director | A 獲配股票 | 1.8K | – | – | 8.2K | SEC |
| 2026-07-01 | 07-06 | Smoter Jennifer Marie | Chief Comm. & Gov. Officer | A 獲配股票 | 18.8K | – | – | 18.8K | SEC |
| 2026-07-01 | 07-06 | Plump Andrew Stewart | President, R&D | A 獲配股票 | 125K | – | – | 932K | SEC |
| 2026-07-01 | 07-06 | Kim Julie So-Young | President and CEO | A 獲配股票 | 50.4K | – | – | 481K | SEC |
| 2026-07-01 | 07-06 | Kim Julie So-Young | President and CEO | A 獲配股票 | 22.8K | – | – | 22.8K | SEC |
| 2026-07-01 | 07-06 | Kim Julie So-Young | President and CEO | A 獲配股票 | 50.4K | – | – | 481K | SEC |
| 2026-07-01 | 07-06 | Kim Julie So-Young | President and CEO | A 獲配股票 | 22.8K | – | – | 22.8K | SEC |
| 2026-07-01 | 07-06 | Bitetti Teresa Marie | President, OBU | A 獲配股票 | 43.9K | – | – | 302K | SEC |
| 2026-07-01 | 07-06 | Duprey Lauren Rusckowski | Chief Transformation Officer | A 獲配股票 | 45.1K | – | – | 274K | SEC |
| 2026-07-01 | 07-06 | Shannon Elaine Mary | Pres., Global Supply & Quality | A 獲配股票 | 30.1K | – | – | 87.7K | SEC |
| 2026-07-01 | 07-06 | Ricci Gabriele | Chief Data & Tech. Officer | A 獲配股票 | 37.6K | – | – | 197K | SEC |
| 2026-07-01 | 07-06 | Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev. | A 獲配股票 | 27.6K | – | – | 200K | SEC |
| 2026-07-01 | 07-06 | Pacheco Rhonda Janice | President, U.S. Business Unit | A 獲配股票 | 50.2K | – | – | 199K | SEC |
| 2026-07-01 | 07-06 | Furney Natalie Anne Marie | Global General Counsel | A 獲配股票 | 43.9K | – | – | 235K | SEC |
| 2026-07-01 | 07-06 | Farajallah Awny Samaan Botros | Chief Medical Officer | A 獲配股票 | 17.6K | – | – | 130K | SEC |
| 2026-07-01 | 07-06 | Greenway Nicola Deidre Petal | Chief Human Resources Officer | A 獲配股票 | 22.6K | – | – | 94.4K | SEC |
| 2026-07-01 | 07-06 | Ibrahim Ramy Riad Ahmed | President, PDT BU | A 獲配股票 | 25.1K | – | – | 110K | SEC |
| 2026-07-01 | 07-06 | Platford Giles Richard | President, IBU | A 獲配股票 | 49.6K | – | – | 347K | SEC |
| 2026-07-01 | 07-06 | Furuta Milano | Chief Financial Officer | A 獲配股票 | 12.3K | – | – | 70.2K | SEC |
| 2026-07-01 | 07-06 | Miyabashira Asuka | President, Japan Pharma B.U. | A 獲配股票 | 1.5K | – | – | 4.5K | SEC |
| 2026-07-01 | 07-06 | Kimura Koichiro | Director | A 獲配股票 | 1.8K | – | – | 1.8K | SEC |
| 2026-04-27 | 04-28 | Pignagnoli Agosti Marcello | Head, Strat. & Port. Dev. | A 獲配股票 | 27.7K | – | – | 172K | SEC |
| 2026-04-27 | 04-28 | Platford Giles Richard | President, IBU | A 獲配股票 | 72.1K | – | – | 297K | SEC |
| 2026-04-27 | 04-28 | Kim Julie So-Young | CEO - Elect | A 獲配股票 | 105K | – | – | 430K | SEC |
| 2026-04-27 | 04-28 | Duprey Lauren Rusckowski | Chief Transformation Officer | A 獲配股票 | 60.0K | – | – | 229K | SEC |
| 2026-04-27 | 04-28 | Bitetti Teresa Marie | President, OBU | A 獲配股票 | 65.0K | – | – | 258K | SEC |
| 2026-04-27 | 04-28 | Ricci Gabriele | Chief Data & Tech. Officer | A 獲配股票 | 35.0K | – | – | 159K | SEC |
| 2026-04-27 | 04-28 | Plump Andrew Stewart | President, R&D | A 獲配股票 | 212K | – | – | 807K | SEC |
| 2026-04-27 | 04-28 | Furuta Milano | Chief Financial Officer | A 獲配股票 | 7.8K | – | – | 57.9K | SEC |
| 2026-04-27 | 04-28 | Weber Christophe Pierre | President and CEO | A 獲配股票 | 78.9K | – | – | 1.0M | SEC |
| 2026-04-27 | 04-28 | Weber Christophe Pierre | President and CEO | A 獲配股票 | 165K | – | – | 419K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| Capital Research Global Investors | 19.3M | 309M | 新進 | 新進 |
| FMR LLC | 9.6M | 154M | 新進 | 新進 |
| MORGAN STANLEY | 7.0M | 112M | 新進 | 新進 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 6.1M | 97.0M | 新進 | 新進 |
| GOLDMAN SACHS GROUP INC | 5.1M | 82.2M | 新進 | 新進 |
| BRANDES INVESTMENT PARTNERS, LP | 4.5M | 72.8M | 新進 | 新進 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 3.7M | 59.8M | 新進 | 新進 |
| BlackRock, Inc. | 3.7M | 59.1M | 新進 | 新進 |
| 文藝復興 RENAISSANCE TECHNOLOGIES LLC | 2.6M | 41.2M | 新進 | 新進 |
| Qube Research & Technologies Ltd | 2.2M | 35.4M | 新進 | 新進 |
| FIRST TRUST ADVISORS LP | 2.1M | 33.9M | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 2.0M | 32.9M | 新進 | 新進 |
| MANAGED ASSET PORTFOLIOS, LLC | 1.8M | 29.2M | 新進 | 新進 |
| NORTHERN TRUST CORP | 1.7M | 27.9M | 新進 | 新進 |
| VAN ECK ASSOCIATES CORP | 1.7M | 26.8M | 新進 | 新進 |
| ENVESTNET ASSET MANAGEMENT INC | 1.6M | 25.6M | 新進 | 新進 |
| AQR CAPITAL MANAGEMENT LLC | 1.5M | 24.5M | 新進 | 新進 |
| Quantinno Capital Management LP | 1.4M | 22.5M | 新進 | 新進 |
| WELLS FARGO & COMPANY/MN | 1.2M | 18.4M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 1.1M | 16.8M | 新進 | 新進 |
| UBS Group AG | 911K | 14.6M | 新進 | 新進 |
| Crossmark Global Holdings, Inc. | 784K | 12.6M | 新進 | 新進 |
| JPMORGAN CHASE & CO | 745K | 11.9M | 新進 | 新進 |
| STIFEL FINANCIAL CORP | 723K | 11.6M | 新進 | 新進 |
| BNP PARIBAS FINANCIAL MARKETS | 714K | 11.4M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 376 +15 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 376 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 104M |
| 合計季末市值 | 1.7B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 4.1M |
|---|---|
| 與上期比 | +36.6% |
| 佔流通股數 | –(外國發行人不算) |
| 日均成交量 | 2.2M |
| 回補天數 | 1.8 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 4.1M | +36.6% | – | 2.2M | 1.8 |
| 2026-08-14 | 3.0M | +4.4% | – | 3.6M | 1.0 |
| 2026-07-31 | 2.9M | -24.9% | – | 4.5M | 1.0 |
| 2026-07-15 | 3.8M | -27.4% | – | 3.0M | 1.3 |
| 2026-06-30 | 5.3M | -2.0% | – | 2.8M | 1.9 |
| 2026-06-15 | 5.4M | +10.0% | – | 3.3M | 1.6 |
| 2026-05-29 | 4.9M | +25.9% | – | 3.0M | 1.6 |
| 2026-05-15 | 3.9M | -22.4% | – | 3.5M | 1.1 |
| 2026-04-30 | 5.0M | +5.5% | – | 2.6M | 2.0 |
| 2026-04-15 | 4.7M | -30.7% | – | 3.2M | 1.5 |
| 2026-03-31 | 6.8M | +16.3% | – | 3.0M | 2.3 |
| 2026-03-13 | 5.9M | -15.8% | – | 2.6M | 2.3 |
| 2026-02-27 | 7.0M | +6.1% | – | 2.6M | 2.7 |
| 2026-02-13 | 6.6M | -15.4% | – | 2.9M | 2.3 |
| 2026-01-30 | 7.8M | -20.9% | – | 4.4M | 1.8 |
| 2026-01-15 | 9.8M | -5.4% | – | 2.5M | 3.9 |
| 2025-12-31 | 10.4M | -10.8% | – | 2.7M | 3.9 |
| 2025-12-15 | 11.6M | +2.3% | – | 2.2M | 5.4 |
| 2025-11-28 | 11.4M | +7.0% | – | 3.1M | 3.7 |
| 2025-11-14 | 10.6M | +20.0% | – | 3.3M | 3.2 |
| 2025-10-31 | 8.9M | -4.7% | – | 2.7M | 3.3 |
| 2025-10-15 | 9.3M | +9.0% | – | 3.1M | 3.0 |
| 2025-09-30 | 8.5M | -8.9% | – | 2.1M | 4.0 |
| 2025-09-15 | 9.4M | +21.8% | – | 3.6M | 2.6 |
| 2025-08-29 | 7.7M | -5.9% | – | 2.8M | 2.8 |
| 2025-08-15 | 8.2M | -0.6% | – | 4.2M | 1.9 |